Leptomeningeal Disease Recruiting Phase 1 Trials for Nivolumab (DB09035)

Also known as: Metastases to meninges / Malignant meningitis / Meningeal Carcinomatosis

IndicationStatusPhase
DBCOND0075962 (Leptomeningeal Disease)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03025256Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal DiseaseTreatment